Medical Devices & Consumables
Global Heart Failure Treatment Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
- Nov 18, 25
- ID: 572871
- Pages: 156
- Figures: 162
- Views: 4
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Heart Failure Treatment Devices market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Abbott
Medtronic
Jarvik Heart
Abiomed
Boston Scientific
Impulse Dynamics
SynCardia
Berlin Heart
Covia Medica
V-Wave
Evaheart
BrioHealth Solutions
Hanyu Medical
NewMed Medical
Valgen Medtech
Segment by Type
Mechanical Assistance Type
Electrical Related Technology
Structural Improvement Type
Segment by Application
GradeⅠ- Ⅳ
Grade Ⅱ- Ⅳ
Grade Ⅲ -IV
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Heart Failure Treatment Devices study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Heart Failure Treatment Devices market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Abbott
Medtronic
Jarvik Heart
Abiomed
Boston Scientific
Impulse Dynamics
SynCardia
Berlin Heart
Covia Medica
V-Wave
Evaheart
BrioHealth Solutions
Hanyu Medical
NewMed Medical
Valgen Medtech
Segment by Type
Mechanical Assistance Type
Electrical Related Technology
Structural Improvement Type
Segment by Application
GradeⅠ- Ⅳ
Grade Ⅱ- Ⅳ
Grade Ⅲ -IV
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Heart Failure Treatment Devices study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
1 Study Coverage
1.1 Introduction to Heart Failure Treatment Devices: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Heart Failure Treatment Devices Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Mechanical Assistance Type
1.2.3 Electrical Related Technology
1.2.4 Structural Improvement Type
1.3 Market Segmentation by Application
1.3.1 Global Heart Failure Treatment Devices Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 GradeⅠ- Ⅳ
1.3.3 Grade Ⅱ- Ⅳ
1.3.4 Grade Ⅲ -IV
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Heart Failure Treatment Devices Revenue Estimates and Forecasts 2020-2031
2.2 Global Heart Failure Treatment Devices Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Heart Failure Treatment Devices Sales Estimates and Forecasts 2020-2031
2.4 Global Heart Failure Treatment Devices Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Heart Failure Treatment Devices Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Heart Failure Treatment Devices Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Mechanical Assistance Type Market Size by Manufacturers
3.5.2 Electrical Related Technology Market Size by Manufacturers
3.5.3 Structural Improvement Type Market Size by Manufacturers
3.6 Global Heart Failure Treatment Devices Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Heart Failure Treatment Devices Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Heart Failure Treatment Devices Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Heart Failure Treatment Devices Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Heart Failure Treatment Devices Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Heart Failure Treatment Devices Sales and Revenue by Type (2020-2031)
6.4 North America Heart Failure Treatment Devices Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Heart Failure Treatment Devices Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Heart Failure Treatment Devices Sales and Revenue by Type (2020-2031)
7.4 Europe Heart Failure Treatment Devices Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Heart Failure Treatment Devices Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Heart Failure Treatment Devices Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Heart Failure Treatment Devices Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Heart Failure Treatment Devices Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Heart Failure Treatment Devices Sales and Revenue by Type (2020-2031)
9.4 Central and South America Heart Failure Treatment Devices Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Heart Failure Treatment Devices Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Heart Failure Treatment Devices Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Heart Failure Treatment Devices Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Heart Failure Treatment Devices Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Abbott
11.1.1 Abbott Corporation Information
11.1.2 Abbott Business Overview
11.1.3 Abbott Heart Failure Treatment Devices Product Models, Descriptions and Specifications
11.1.4 Abbott Heart Failure Treatment Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Abbott Heart Failure Treatment Devices Sales by Product in 2024
11.1.6 Abbott Heart Failure Treatment Devices Sales by Application in 2024
11.1.7 Abbott Heart Failure Treatment Devices Sales by Geographic Area in 2024
11.1.8 Abbott Heart Failure Treatment Devices SWOT Analysis
11.1.9 Abbott Recent Developments
11.2 Medtronic
11.2.1 Medtronic Corporation Information
11.2.2 Medtronic Business Overview
11.2.3 Medtronic Heart Failure Treatment Devices Product Models, Descriptions and Specifications
11.2.4 Medtronic Heart Failure Treatment Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Medtronic Heart Failure Treatment Devices Sales by Product in 2024
11.2.6 Medtronic Heart Failure Treatment Devices Sales by Application in 2024
11.2.7 Medtronic Heart Failure Treatment Devices Sales by Geographic Area in 2024
11.2.8 Medtronic Heart Failure Treatment Devices SWOT Analysis
11.2.9 Medtronic Recent Developments
11.3 Jarvik Heart
11.3.1 Jarvik Heart Corporation Information
11.3.2 Jarvik Heart Business Overview
11.3.3 Jarvik Heart Heart Failure Treatment Devices Product Models, Descriptions and Specifications
11.3.4 Jarvik Heart Heart Failure Treatment Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Jarvik Heart Heart Failure Treatment Devices Sales by Product in 2024
11.3.6 Jarvik Heart Heart Failure Treatment Devices Sales by Application in 2024
11.3.7 Jarvik Heart Heart Failure Treatment Devices Sales by Geographic Area in 2024
11.3.8 Jarvik Heart Heart Failure Treatment Devices SWOT Analysis
11.3.9 Jarvik Heart Recent Developments
11.4 Abiomed
11.4.1 Abiomed Corporation Information
11.4.2 Abiomed Business Overview
11.4.3 Abiomed Heart Failure Treatment Devices Product Models, Descriptions and Specifications
11.4.4 Abiomed Heart Failure Treatment Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Abiomed Heart Failure Treatment Devices Sales by Product in 2024
11.4.6 Abiomed Heart Failure Treatment Devices Sales by Application in 2024
11.4.7 Abiomed Heart Failure Treatment Devices Sales by Geographic Area in 2024
11.4.8 Abiomed Heart Failure Treatment Devices SWOT Analysis
11.4.9 Abiomed Recent Developments
11.5 Boston Scientific
11.5.1 Boston Scientific Corporation Information
11.5.2 Boston Scientific Business Overview
11.5.3 Boston Scientific Heart Failure Treatment Devices Product Models, Descriptions and Specifications
11.5.4 Boston Scientific Heart Failure Treatment Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Boston Scientific Heart Failure Treatment Devices Sales by Product in 2024
11.5.6 Boston Scientific Heart Failure Treatment Devices Sales by Application in 2024
11.5.7 Boston Scientific Heart Failure Treatment Devices Sales by Geographic Area in 2024
11.5.8 Boston Scientific Heart Failure Treatment Devices SWOT Analysis
11.5.9 Boston Scientific Recent Developments
11.6 Impulse Dynamics
11.6.1 Impulse Dynamics Corporation Information
11.6.2 Impulse Dynamics Business Overview
11.6.3 Impulse Dynamics Heart Failure Treatment Devices Product Models, Descriptions and Specifications
11.6.4 Impulse Dynamics Heart Failure Treatment Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Impulse Dynamics Recent Developments
11.7 SynCardia
11.7.1 SynCardia Corporation Information
11.7.2 SynCardia Business Overview
11.7.3 SynCardia Heart Failure Treatment Devices Product Models, Descriptions and Specifications
11.7.4 SynCardia Heart Failure Treatment Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 SynCardia Recent Developments
11.8 Berlin Heart
11.8.1 Berlin Heart Corporation Information
11.8.2 Berlin Heart Business Overview
11.8.3 Berlin Heart Heart Failure Treatment Devices Product Models, Descriptions and Specifications
11.8.4 Berlin Heart Heart Failure Treatment Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Berlin Heart Recent Developments
11.9 Covia Medica
11.9.1 Covia Medica Corporation Information
11.9.2 Covia Medica Business Overview
11.9.3 Covia Medica Heart Failure Treatment Devices Product Models, Descriptions and Specifications
11.9.4 Covia Medica Heart Failure Treatment Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Covia Medica Recent Developments
11.10 V-Wave
11.10.1 V-Wave Corporation Information
11.10.2 V-Wave Business Overview
11.10.3 V-Wave Heart Failure Treatment Devices Product Models, Descriptions and Specifications
11.10.4 V-Wave Heart Failure Treatment Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 V-Wave Recent Developments
11.11 Evaheart
11.11.1 Evaheart Corporation Information
11.11.2 Evaheart Business Overview
11.11.3 Evaheart Heart Failure Treatment Devices Product Models, Descriptions and Specifications
11.11.4 Evaheart Heart Failure Treatment Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Evaheart Recent Developments
11.12 BrioHealth Solutions
11.12.1 BrioHealth Solutions Corporation Information
11.12.2 BrioHealth Solutions Business Overview
11.12.3 BrioHealth Solutions Heart Failure Treatment Devices Product Models, Descriptions and Specifications
11.12.4 BrioHealth Solutions Heart Failure Treatment Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 BrioHealth Solutions Recent Developments
11.13 Hanyu Medical
11.13.1 Hanyu Medical Corporation Information
11.13.2 Hanyu Medical Business Overview
11.13.3 Hanyu Medical Heart Failure Treatment Devices Product Models, Descriptions and Specifications
11.13.4 Hanyu Medical Heart Failure Treatment Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Hanyu Medical Recent Developments
11.14 NewMed Medical
11.14.1 NewMed Medical Corporation Information
11.14.2 NewMed Medical Business Overview
11.14.3 NewMed Medical Heart Failure Treatment Devices Product Models, Descriptions and Specifications
11.14.4 NewMed Medical Heart Failure Treatment Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 NewMed Medical Recent Developments
11.15 Valgen Medtech
11.15.1 Valgen Medtech Corporation Information
11.15.2 Valgen Medtech Business Overview
11.15.3 Valgen Medtech Heart Failure Treatment Devices Product Models, Descriptions and Specifications
11.15.4 Valgen Medtech Heart Failure Treatment Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Valgen Medtech Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Heart Failure Treatment Devices Industry Chain
12.2 Heart Failure Treatment Devices Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Heart Failure Treatment Devices Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Heart Failure Treatment Devices Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Heart Failure Treatment Devices Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Heart Failure Treatment Devices Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
1.1 Introduction to Heart Failure Treatment Devices: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Heart Failure Treatment Devices Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Mechanical Assistance Type
1.2.3 Electrical Related Technology
1.2.4 Structural Improvement Type
1.3 Market Segmentation by Application
1.3.1 Global Heart Failure Treatment Devices Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 GradeⅠ- Ⅳ
1.3.3 Grade Ⅱ- Ⅳ
1.3.4 Grade Ⅲ -IV
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Heart Failure Treatment Devices Revenue Estimates and Forecasts 2020-2031
2.2 Global Heart Failure Treatment Devices Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Heart Failure Treatment Devices Sales Estimates and Forecasts 2020-2031
2.4 Global Heart Failure Treatment Devices Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Heart Failure Treatment Devices Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Heart Failure Treatment Devices Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Mechanical Assistance Type Market Size by Manufacturers
3.5.2 Electrical Related Technology Market Size by Manufacturers
3.5.3 Structural Improvement Type Market Size by Manufacturers
3.6 Global Heart Failure Treatment Devices Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Heart Failure Treatment Devices Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Heart Failure Treatment Devices Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Heart Failure Treatment Devices Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Heart Failure Treatment Devices Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Heart Failure Treatment Devices Sales and Revenue by Type (2020-2031)
6.4 North America Heart Failure Treatment Devices Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Heart Failure Treatment Devices Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Heart Failure Treatment Devices Sales and Revenue by Type (2020-2031)
7.4 Europe Heart Failure Treatment Devices Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Heart Failure Treatment Devices Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Heart Failure Treatment Devices Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Heart Failure Treatment Devices Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Heart Failure Treatment Devices Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Heart Failure Treatment Devices Sales and Revenue by Type (2020-2031)
9.4 Central and South America Heart Failure Treatment Devices Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Heart Failure Treatment Devices Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Heart Failure Treatment Devices Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Heart Failure Treatment Devices Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Heart Failure Treatment Devices Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Abbott
11.1.1 Abbott Corporation Information
11.1.2 Abbott Business Overview
11.1.3 Abbott Heart Failure Treatment Devices Product Models, Descriptions and Specifications
11.1.4 Abbott Heart Failure Treatment Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Abbott Heart Failure Treatment Devices Sales by Product in 2024
11.1.6 Abbott Heart Failure Treatment Devices Sales by Application in 2024
11.1.7 Abbott Heart Failure Treatment Devices Sales by Geographic Area in 2024
11.1.8 Abbott Heart Failure Treatment Devices SWOT Analysis
11.1.9 Abbott Recent Developments
11.2 Medtronic
11.2.1 Medtronic Corporation Information
11.2.2 Medtronic Business Overview
11.2.3 Medtronic Heart Failure Treatment Devices Product Models, Descriptions and Specifications
11.2.4 Medtronic Heart Failure Treatment Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Medtronic Heart Failure Treatment Devices Sales by Product in 2024
11.2.6 Medtronic Heart Failure Treatment Devices Sales by Application in 2024
11.2.7 Medtronic Heart Failure Treatment Devices Sales by Geographic Area in 2024
11.2.8 Medtronic Heart Failure Treatment Devices SWOT Analysis
11.2.9 Medtronic Recent Developments
11.3 Jarvik Heart
11.3.1 Jarvik Heart Corporation Information
11.3.2 Jarvik Heart Business Overview
11.3.3 Jarvik Heart Heart Failure Treatment Devices Product Models, Descriptions and Specifications
11.3.4 Jarvik Heart Heart Failure Treatment Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Jarvik Heart Heart Failure Treatment Devices Sales by Product in 2024
11.3.6 Jarvik Heart Heart Failure Treatment Devices Sales by Application in 2024
11.3.7 Jarvik Heart Heart Failure Treatment Devices Sales by Geographic Area in 2024
11.3.8 Jarvik Heart Heart Failure Treatment Devices SWOT Analysis
11.3.9 Jarvik Heart Recent Developments
11.4 Abiomed
11.4.1 Abiomed Corporation Information
11.4.2 Abiomed Business Overview
11.4.3 Abiomed Heart Failure Treatment Devices Product Models, Descriptions and Specifications
11.4.4 Abiomed Heart Failure Treatment Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Abiomed Heart Failure Treatment Devices Sales by Product in 2024
11.4.6 Abiomed Heart Failure Treatment Devices Sales by Application in 2024
11.4.7 Abiomed Heart Failure Treatment Devices Sales by Geographic Area in 2024
11.4.8 Abiomed Heart Failure Treatment Devices SWOT Analysis
11.4.9 Abiomed Recent Developments
11.5 Boston Scientific
11.5.1 Boston Scientific Corporation Information
11.5.2 Boston Scientific Business Overview
11.5.3 Boston Scientific Heart Failure Treatment Devices Product Models, Descriptions and Specifications
11.5.4 Boston Scientific Heart Failure Treatment Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Boston Scientific Heart Failure Treatment Devices Sales by Product in 2024
11.5.6 Boston Scientific Heart Failure Treatment Devices Sales by Application in 2024
11.5.7 Boston Scientific Heart Failure Treatment Devices Sales by Geographic Area in 2024
11.5.8 Boston Scientific Heart Failure Treatment Devices SWOT Analysis
11.5.9 Boston Scientific Recent Developments
11.6 Impulse Dynamics
11.6.1 Impulse Dynamics Corporation Information
11.6.2 Impulse Dynamics Business Overview
11.6.3 Impulse Dynamics Heart Failure Treatment Devices Product Models, Descriptions and Specifications
11.6.4 Impulse Dynamics Heart Failure Treatment Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Impulse Dynamics Recent Developments
11.7 SynCardia
11.7.1 SynCardia Corporation Information
11.7.2 SynCardia Business Overview
11.7.3 SynCardia Heart Failure Treatment Devices Product Models, Descriptions and Specifications
11.7.4 SynCardia Heart Failure Treatment Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 SynCardia Recent Developments
11.8 Berlin Heart
11.8.1 Berlin Heart Corporation Information
11.8.2 Berlin Heart Business Overview
11.8.3 Berlin Heart Heart Failure Treatment Devices Product Models, Descriptions and Specifications
11.8.4 Berlin Heart Heart Failure Treatment Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Berlin Heart Recent Developments
11.9 Covia Medica
11.9.1 Covia Medica Corporation Information
11.9.2 Covia Medica Business Overview
11.9.3 Covia Medica Heart Failure Treatment Devices Product Models, Descriptions and Specifications
11.9.4 Covia Medica Heart Failure Treatment Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Covia Medica Recent Developments
11.10 V-Wave
11.10.1 V-Wave Corporation Information
11.10.2 V-Wave Business Overview
11.10.3 V-Wave Heart Failure Treatment Devices Product Models, Descriptions and Specifications
11.10.4 V-Wave Heart Failure Treatment Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 V-Wave Recent Developments
11.11 Evaheart
11.11.1 Evaheart Corporation Information
11.11.2 Evaheart Business Overview
11.11.3 Evaheart Heart Failure Treatment Devices Product Models, Descriptions and Specifications
11.11.4 Evaheart Heart Failure Treatment Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Evaheart Recent Developments
11.12 BrioHealth Solutions
11.12.1 BrioHealth Solutions Corporation Information
11.12.2 BrioHealth Solutions Business Overview
11.12.3 BrioHealth Solutions Heart Failure Treatment Devices Product Models, Descriptions and Specifications
11.12.4 BrioHealth Solutions Heart Failure Treatment Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 BrioHealth Solutions Recent Developments
11.13 Hanyu Medical
11.13.1 Hanyu Medical Corporation Information
11.13.2 Hanyu Medical Business Overview
11.13.3 Hanyu Medical Heart Failure Treatment Devices Product Models, Descriptions and Specifications
11.13.4 Hanyu Medical Heart Failure Treatment Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Hanyu Medical Recent Developments
11.14 NewMed Medical
11.14.1 NewMed Medical Corporation Information
11.14.2 NewMed Medical Business Overview
11.14.3 NewMed Medical Heart Failure Treatment Devices Product Models, Descriptions and Specifications
11.14.4 NewMed Medical Heart Failure Treatment Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 NewMed Medical Recent Developments
11.15 Valgen Medtech
11.15.1 Valgen Medtech Corporation Information
11.15.2 Valgen Medtech Business Overview
11.15.3 Valgen Medtech Heart Failure Treatment Devices Product Models, Descriptions and Specifications
11.15.4 Valgen Medtech Heart Failure Treatment Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Valgen Medtech Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Heart Failure Treatment Devices Industry Chain
12.2 Heart Failure Treatment Devices Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Heart Failure Treatment Devices Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Heart Failure Treatment Devices Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Heart Failure Treatment Devices Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Heart Failure Treatment Devices Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Heart Failure Treatment Devices Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Heart Failure Treatment Devices Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Heart Failure Treatment Devices Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Heart Failure Treatment Devices Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Heart Failure Treatment Devices Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Heart Failure Treatment Devices Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
Table 7. Global Heart Failure Treatment Devices Sales by Region (2020-2025) & (Units)
Table 8. Global Heart Failure Treatment Devices Sales by Region (2026-2031) & (Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Heart Failure Treatment Devices Sales by Manufacturers (2020-2025) & (Units)
Table 11. Global Heart Failure Treatment Devices Sales Share by Manufacturers (2020-2025)
Table 12. Global Heart Failure Treatment Devices Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Heart Failure Treatment Devices Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Heart Failure Treatment Devices by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heart Failure Treatment Devices as of 2024)
Table 16. Global Heart Failure Treatment Devices Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Heart Failure Treatment Devices Average Selling Price (ASP) by Manufacturers (2020-2025) & (K US$/Unit)
Table 18. Key Manufacturers Heart Failure Treatment Devices Manufacturing Base and Headquarters
Table 19. Global Heart Failure Treatment Devices Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Heart Failure Treatment Devices Sales by Type (2020-2025) & (Units)
Table 23. Global Heart Failure Treatment Devices Sales by Type (2026-2031) & (Units)
Table 24. Global Heart Failure Treatment Devices Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Heart Failure Treatment Devices Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Heart Failure Treatment Devices ASP by Type (2020-2031) & (K US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Heart Failure Treatment Devices Sales by Application (2020-2025) & (Units)
Table 29. Global Heart Failure Treatment Devices Sales by Application (2026-2031) & (Units)
Table 30. Heart Failure Treatment Devices High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Heart Failure Treatment Devices Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Heart Failure Treatment Devices Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Heart Failure Treatment Devices ASP by Application (2020-2031) & (K US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Heart Failure Treatment Devices Growth Accelerators and Market Barriers
Table 37. North America Heart Failure Treatment Devices Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Heart Failure Treatment Devices Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Heart Failure Treatment Devices Growth Accelerators and Market Barriers
Table 40. Europe Heart Failure Treatment Devices Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Heart Failure Treatment Devices Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Heart Failure Treatment Devices Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Heart Failure Treatment Devices Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Heart Failure Treatment Devices Growth Accelerators and Market Barriers
Table 45. Southeast Asia Heart Failure Treatment Devices Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Heart Failure Treatment Devices Investment Opportunities and Key Challenges
Table 47. Central and South America Heart Failure Treatment Devices Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Heart Failure Treatment Devices Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Heart Failure Treatment Devices Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Abbott Corporation Information
Table 51. Abbott Description and Major Businesses
Table 52. Abbott Product Models, Descriptions and Specifications
Table 53. Abbott Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 54. Abbott Sales Value Proportion by Product in 2024
Table 55. Abbott Sales Value Proportion by Application in 2024
Table 56. Abbott Sales Value Proportion by Geographic Area in 2024
Table 57. Abbott Heart Failure Treatment Devices SWOT Analysis
Table 58. Abbott Recent Developments
Table 59. Medtronic Corporation Information
Table 60. Medtronic Description and Major Businesses
Table 61. Medtronic Product Models, Descriptions and Specifications
Table 62. Medtronic Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 63. Medtronic Sales Value Proportion by Product in 2024
Table 64. Medtronic Sales Value Proportion by Application in 2024
Table 65. Medtronic Sales Value Proportion by Geographic Area in 2024
Table 66. Medtronic Heart Failure Treatment Devices SWOT Analysis
Table 67. Medtronic Recent Developments
Table 68. Jarvik Heart Corporation Information
Table 69. Jarvik Heart Description and Major Businesses
Table 70. Jarvik Heart Product Models, Descriptions and Specifications
Table 71. Jarvik Heart Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 72. Jarvik Heart Sales Value Proportion by Product in 2024
Table 73. Jarvik Heart Sales Value Proportion by Application in 2024
Table 74. Jarvik Heart Sales Value Proportion by Geographic Area in 2024
Table 75. Jarvik Heart Heart Failure Treatment Devices SWOT Analysis
Table 76. Jarvik Heart Recent Developments
Table 77. Abiomed Corporation Information
Table 78. Abiomed Description and Major Businesses
Table 79. Abiomed Product Models, Descriptions and Specifications
Table 80. Abiomed Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 81. Abiomed Sales Value Proportion by Product in 2024
Table 82. Abiomed Sales Value Proportion by Application in 2024
Table 83. Abiomed Sales Value Proportion by Geographic Area in 2024
Table 84. Abiomed Heart Failure Treatment Devices SWOT Analysis
Table 85. Abiomed Recent Developments
Table 86. Boston Scientific Corporation Information
Table 87. Boston Scientific Description and Major Businesses
Table 88. Boston Scientific Product Models, Descriptions and Specifications
Table 89. Boston Scientific Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 90. Boston Scientific Sales Value Proportion by Product in 2024
Table 91. Boston Scientific Sales Value Proportion by Application in 2024
Table 92. Boston Scientific Sales Value Proportion by Geographic Area in 2024
Table 93. Boston Scientific Heart Failure Treatment Devices SWOT Analysis
Table 94. Boston Scientific Recent Developments
Table 95. Impulse Dynamics Corporation Information
Table 96. Impulse Dynamics Description and Major Businesses
Table 97. Impulse Dynamics Product Models, Descriptions and Specifications
Table 98. Impulse Dynamics Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 99. Impulse Dynamics Recent Developments
Table 100. SynCardia Corporation Information
Table 101. SynCardia Description and Major Businesses
Table 102. SynCardia Product Models, Descriptions and Specifications
Table 103. SynCardia Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 104. SynCardia Recent Developments
Table 105. Berlin Heart Corporation Information
Table 106. Berlin Heart Description and Major Businesses
Table 107. Berlin Heart Product Models, Descriptions and Specifications
Table 108. Berlin Heart Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 109. Berlin Heart Recent Developments
Table 110. Covia Medica Corporation Information
Table 111. Covia Medica Description and Major Businesses
Table 112. Covia Medica Product Models, Descriptions and Specifications
Table 113. Covia Medica Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 114. Covia Medica Recent Developments
Table 115. V-Wave Corporation Information
Table 116. V-Wave Description and Major Businesses
Table 117. V-Wave Product Models, Descriptions and Specifications
Table 118. V-Wave Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 119. V-Wave Recent Developments
Table 120. Evaheart Corporation Information
Table 121. Evaheart Description and Major Businesses
Table 122. Evaheart Product Models, Descriptions and Specifications
Table 123. Evaheart Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 124. Evaheart Recent Developments
Table 125. BrioHealth Solutions Corporation Information
Table 126. BrioHealth Solutions Description and Major Businesses
Table 127. BrioHealth Solutions Product Models, Descriptions and Specifications
Table 128. BrioHealth Solutions Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 129. BrioHealth Solutions Recent Developments
Table 130. Hanyu Medical Corporation Information
Table 131. Hanyu Medical Description and Major Businesses
Table 132. Hanyu Medical Product Models, Descriptions and Specifications
Table 133. Hanyu Medical Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 134. Hanyu Medical Recent Developments
Table 135. NewMed Medical Corporation Information
Table 136. NewMed Medical Description and Major Businesses
Table 137. NewMed Medical Product Models, Descriptions and Specifications
Table 138. NewMed Medical Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 139. NewMed Medical Recent Developments
Table 140. Valgen Medtech Corporation Information
Table 141. Valgen Medtech Description and Major Businesses
Table 142. Valgen Medtech Product Models, Descriptions and Specifications
Table 143. Valgen Medtech Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 144. Valgen Medtech Recent Developments
Table 145. Key Raw Materials Distribution
Table 146. Raw Materials Key Suppliers
Table 147. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 148. Milestones in Production Technology Evolution
Table 149. Distributors List
Table 150. Market Trends and Market Evolution
Table 151. Market Drivers and Opportunities
Table 152. Market Challenges, Risks, and Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Heart Failure Treatment Devices Product Picture
Figure 2. Global Heart Failure Treatment Devices Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Mechanical Assistance Type Product Picture
Figure 4. Electrical Related Technology Product Picture
Figure 5. Structural Improvement Type Product Picture
Figure 6. Global Heart Failure Treatment Devices Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. GradeⅠ- Ⅳ
Figure 8. Grade Ⅱ- Ⅳ
Figure 9. Grade Ⅲ -IV
Figure 10. Heart Failure Treatment Devices Report Years Considered
Figure 11. Global Heart Failure Treatment Devices Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Heart Failure Treatment Devices Revenue (2020-2031) & (US$ Million)
Figure 13. Global Heart Failure Treatment Devices Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Heart Failure Treatment Devices Revenue Market Share by Region (2020-2031)
Figure 15. Global Heart Failure Treatment Devices Sales (2020-2031) & (Units)
Figure 16. Global Heart Failure Treatment Devices Sales (CAGR) by Region (2020-2031) (Units)
Figure 17. Global Heart Failure Treatment Devices Sales Market Share by Region (2020-2031)
Figure 18. Top 5 and Top 10 Manufacturers Heart Failure Treatment Devices Sales Volume Market Share in 2024
Figure 19. Global Heart Failure Treatment Devices Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. Mechanical Assistance Type Revenue Market Share by Manufacturer in 2024
Figure 22. Electrical Related Technology Revenue Market Share by Manufacturer in 2024
Figure 23. Structural Improvement Type Revenue Market Share by Manufacturer in 2024
Figure 24. Global Heart Failure Treatment Devices Sales Market Share by Type (2020-2031)
Figure 25. Global Heart Failure Treatment Devices Revenue Market Share by Type (2020-2031)
Figure 26. Global Heart Failure Treatment Devices Sales Market Share by Application (2020-2031)
Figure 27. Global Heart Failure Treatment Devices Revenue Market Share by Application (2020-2031)
Figure 28. North America Heart Failure Treatment Devices Sales YoY (2020-2031) & (Units)
Figure 29. North America Heart Failure Treatment Devices Revenue YoY (2020-2031) & (US$ Million)
Figure 30. North America Top 5 Manufacturers Heart Failure Treatment Devices Sales Revenue (US$ Million) in 2024
Figure 31. North America Heart Failure Treatment Devices Sales Volume (Units) by Type (2020- 2031)
Figure 32. North America Heart Failure Treatment Devices Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 33. North America Heart Failure Treatment Devices Sales Volume (Units) by Application (2020-2031)
Figure 34. North America Heart Failure Treatment Devices Sales Revenue (US$ Million) by Application (2020-2031)
Figure 35. US Heart Failure Treatment Devices Revenue (2020-2031) & (US$ Million)
Figure 36. Canada Heart Failure Treatment Devices Revenue (2020-2031) & (US$ Million)
Figure 37. Mexico Heart Failure Treatment Devices Revenue (2020-2031) & (US$ Million)
Figure 38. Europe Heart Failure Treatment Devices Sales YoY (2020-2031) & (Units)
Figure 39. Europe Heart Failure Treatment Devices Revenue YoY (2020-2031) & (US$ Million)
Figure 40. Europe Top 5 Manufacturers Heart Failure Treatment Devices Sales Revenue (US$ Million) in 2024
Figure 41. Europe Heart Failure Treatment Devices Sales Volume (Units) by Type (2020-2031)
Figure 42. Europe Heart Failure Treatment Devices Sales Revenue (US$ Million) by Type (2020-2031)
Figure 43. Europe Heart Failure Treatment Devices Sales Volume (Units) by Application (2020-2031)
Figure 44. Europe Heart Failure Treatment Devices Sales Revenue (US$ Million) by Application (2020-2031)
Figure 45. Germany Heart Failure Treatment Devices Revenue (2020-2031) & (US$ Million)
Figure 46. France Heart Failure Treatment Devices Revenue (2020-2031) & (US$ Million)
Figure 47. U.K. Heart Failure Treatment Devices Revenue (2020-2031) & (US$ Million)
Figure 48. Italy Heart Failure Treatment Devices Revenue (2020-2031) & (US$ Million)
Figure 49. Russia Heart Failure Treatment Devices Revenue (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Heart Failure Treatment Devices Sales YoY (2020-2031) & (Units)
Figure 51. Asia-Pacific Heart Failure Treatment Devices Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific Top 8 Manufacturers Heart Failure Treatment Devices Sales Revenue (US$ Million) in 2024
Figure 53. Asia-Pacific Heart Failure Treatment Devices Sales Volume (Units) by Type (2020- 2031)
Figure 54. Asia-Pacific Heart Failure Treatment Devices Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 55. Asia-Pacific Heart Failure Treatment Devices Sales Volume (Units) by Application (2020-2031)
Figure 56. Asia-Pacific Heart Failure Treatment Devices Sales Revenue (US$ Million) by Application (2020-2031)
Figure 57. Indonesia Heart Failure Treatment Devices Revenue (2020-2031) & (US$ Million)
Figure 58. Japan Heart Failure Treatment Devices Revenue (2020-2031) & (US$ Million)
Figure 59. South Korea Heart Failure Treatment Devices Revenue (2020-2031) & (US$ Million)
Figure 60. China Taiwan Heart Failure Treatment Devices Revenue (2020-2031) & (US$ Million)
Figure 61. India Heart Failure Treatment Devices Revenue (2020-2031) & (US$ Million)
Figure 62. Central and South America Heart Failure Treatment Devices Sales YoY (2020-2031) & (Units)
Figure 63. Central and South America Heart Failure Treatment Devices Revenue YoY (2020-2031) & (US$ Million)
Figure 64. Central and South America Top 5 Manufacturers Heart Failure Treatment Devices Sales Revenue (US$ Million) in 2024
Figure 65. Central and South America Heart Failure Treatment Devices Sales Volume (Units) by Type (2021-2031)
Figure 66. Central and South America Heart Failure Treatment Devices Sales Revenue (US$ Million) by Type (2020-2031)
Figure 67. Central and South America Heart Failure Treatment Devices Sales Volume (Units) by Application (2020-2031)
Figure 68. Central and South America Heart Failure Treatment Devices Sales Revenue (US$ Million) by Application (2020-2031)
Figure 69. Brazil Heart Failure Treatment Devices Revenue (2020-2025) & (US$ Million)
Figure 70. Argentina Heart Failure Treatment Devices Revenue (2020-2025) & (US$ Million)
Figure 71. Middle East, and Africa Heart Failure Treatment Devices Sales YoY (2020-2031) & (Units)
Figure 72. Middle East and Africa Heart Failure Treatment Devices Revenue YoY (2020-2031) & (US$ Million)
Figure 73. Middle East and Africa Top 5 Manufacturers Heart Failure Treatment Devices Sales Revenue (US$ Million) in 2024
Figure 74. Middle East and Africa Heart Failure Treatment Devices Sales Volume (Units) by Type (2021-2031)
Figure 75. South America Heart Failure Treatment Devices Sales Revenue (US$ Million) by Type (2020-2031)
Figure 76. Middle East and Africa Heart Failure Treatment Devices Sales Volume (Units) by Application (2020-2031)
Figure 77. Middle East and Africa Heart Failure Treatment Devices Sales Revenue (US$ Million) by Application (2020-2031)
Figure 78. GCC Countries Heart Failure Treatment Devices Revenue (2020-2025) & (US$ Million)
Figure 79. Turkey Heart Failure Treatment Devices Revenue (2020-2025) & (US$ Million)
Figure 80. Egypt Heart Failure Treatment Devices Revenue (2020-2025) & (US$ Million)
Figure 81. South Africa Heart Failure Treatment Devices Revenue (2020-2025) & (US$ Million)
Figure 82. Heart Failure Treatment Devices Industry Chain Mapping
Figure 83. Regional Heart Failure Treatment Devices Manufacturing Base Distribution (%)
Figure 84. Global Heart Failure Treatment Devices Production Market Share by Region (2020-2031)
Figure 85. Heart Failure Treatment Devices Production Process
Figure 86. Regional Heart Failure Treatment Devices Production Cost Structure
Figure 87. Channels of Distribution (Direct Vs Distribution)
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
Table 1. Global Heart Failure Treatment Devices Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Heart Failure Treatment Devices Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Heart Failure Treatment Devices Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Heart Failure Treatment Devices Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Heart Failure Treatment Devices Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Heart Failure Treatment Devices Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
Table 7. Global Heart Failure Treatment Devices Sales by Region (2020-2025) & (Units)
Table 8. Global Heart Failure Treatment Devices Sales by Region (2026-2031) & (Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Heart Failure Treatment Devices Sales by Manufacturers (2020-2025) & (Units)
Table 11. Global Heart Failure Treatment Devices Sales Share by Manufacturers (2020-2025)
Table 12. Global Heart Failure Treatment Devices Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Heart Failure Treatment Devices Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Heart Failure Treatment Devices by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heart Failure Treatment Devices as of 2024)
Table 16. Global Heart Failure Treatment Devices Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Heart Failure Treatment Devices Average Selling Price (ASP) by Manufacturers (2020-2025) & (K US$/Unit)
Table 18. Key Manufacturers Heart Failure Treatment Devices Manufacturing Base and Headquarters
Table 19. Global Heart Failure Treatment Devices Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Heart Failure Treatment Devices Sales by Type (2020-2025) & (Units)
Table 23. Global Heart Failure Treatment Devices Sales by Type (2026-2031) & (Units)
Table 24. Global Heart Failure Treatment Devices Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Heart Failure Treatment Devices Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Heart Failure Treatment Devices ASP by Type (2020-2031) & (K US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Heart Failure Treatment Devices Sales by Application (2020-2025) & (Units)
Table 29. Global Heart Failure Treatment Devices Sales by Application (2026-2031) & (Units)
Table 30. Heart Failure Treatment Devices High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Heart Failure Treatment Devices Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Heart Failure Treatment Devices Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Heart Failure Treatment Devices ASP by Application (2020-2031) & (K US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Heart Failure Treatment Devices Growth Accelerators and Market Barriers
Table 37. North America Heart Failure Treatment Devices Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Heart Failure Treatment Devices Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Heart Failure Treatment Devices Growth Accelerators and Market Barriers
Table 40. Europe Heart Failure Treatment Devices Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Heart Failure Treatment Devices Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Heart Failure Treatment Devices Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Heart Failure Treatment Devices Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Heart Failure Treatment Devices Growth Accelerators and Market Barriers
Table 45. Southeast Asia Heart Failure Treatment Devices Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Heart Failure Treatment Devices Investment Opportunities and Key Challenges
Table 47. Central and South America Heart Failure Treatment Devices Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Heart Failure Treatment Devices Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Heart Failure Treatment Devices Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Abbott Corporation Information
Table 51. Abbott Description and Major Businesses
Table 52. Abbott Product Models, Descriptions and Specifications
Table 53. Abbott Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 54. Abbott Sales Value Proportion by Product in 2024
Table 55. Abbott Sales Value Proportion by Application in 2024
Table 56. Abbott Sales Value Proportion by Geographic Area in 2024
Table 57. Abbott Heart Failure Treatment Devices SWOT Analysis
Table 58. Abbott Recent Developments
Table 59. Medtronic Corporation Information
Table 60. Medtronic Description and Major Businesses
Table 61. Medtronic Product Models, Descriptions and Specifications
Table 62. Medtronic Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 63. Medtronic Sales Value Proportion by Product in 2024
Table 64. Medtronic Sales Value Proportion by Application in 2024
Table 65. Medtronic Sales Value Proportion by Geographic Area in 2024
Table 66. Medtronic Heart Failure Treatment Devices SWOT Analysis
Table 67. Medtronic Recent Developments
Table 68. Jarvik Heart Corporation Information
Table 69. Jarvik Heart Description and Major Businesses
Table 70. Jarvik Heart Product Models, Descriptions and Specifications
Table 71. Jarvik Heart Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 72. Jarvik Heart Sales Value Proportion by Product in 2024
Table 73. Jarvik Heart Sales Value Proportion by Application in 2024
Table 74. Jarvik Heart Sales Value Proportion by Geographic Area in 2024
Table 75. Jarvik Heart Heart Failure Treatment Devices SWOT Analysis
Table 76. Jarvik Heart Recent Developments
Table 77. Abiomed Corporation Information
Table 78. Abiomed Description and Major Businesses
Table 79. Abiomed Product Models, Descriptions and Specifications
Table 80. Abiomed Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 81. Abiomed Sales Value Proportion by Product in 2024
Table 82. Abiomed Sales Value Proportion by Application in 2024
Table 83. Abiomed Sales Value Proportion by Geographic Area in 2024
Table 84. Abiomed Heart Failure Treatment Devices SWOT Analysis
Table 85. Abiomed Recent Developments
Table 86. Boston Scientific Corporation Information
Table 87. Boston Scientific Description and Major Businesses
Table 88. Boston Scientific Product Models, Descriptions and Specifications
Table 89. Boston Scientific Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 90. Boston Scientific Sales Value Proportion by Product in 2024
Table 91. Boston Scientific Sales Value Proportion by Application in 2024
Table 92. Boston Scientific Sales Value Proportion by Geographic Area in 2024
Table 93. Boston Scientific Heart Failure Treatment Devices SWOT Analysis
Table 94. Boston Scientific Recent Developments
Table 95. Impulse Dynamics Corporation Information
Table 96. Impulse Dynamics Description and Major Businesses
Table 97. Impulse Dynamics Product Models, Descriptions and Specifications
Table 98. Impulse Dynamics Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 99. Impulse Dynamics Recent Developments
Table 100. SynCardia Corporation Information
Table 101. SynCardia Description and Major Businesses
Table 102. SynCardia Product Models, Descriptions and Specifications
Table 103. SynCardia Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 104. SynCardia Recent Developments
Table 105. Berlin Heart Corporation Information
Table 106. Berlin Heart Description and Major Businesses
Table 107. Berlin Heart Product Models, Descriptions and Specifications
Table 108. Berlin Heart Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 109. Berlin Heart Recent Developments
Table 110. Covia Medica Corporation Information
Table 111. Covia Medica Description and Major Businesses
Table 112. Covia Medica Product Models, Descriptions and Specifications
Table 113. Covia Medica Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 114. Covia Medica Recent Developments
Table 115. V-Wave Corporation Information
Table 116. V-Wave Description and Major Businesses
Table 117. V-Wave Product Models, Descriptions and Specifications
Table 118. V-Wave Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 119. V-Wave Recent Developments
Table 120. Evaheart Corporation Information
Table 121. Evaheart Description and Major Businesses
Table 122. Evaheart Product Models, Descriptions and Specifications
Table 123. Evaheart Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 124. Evaheart Recent Developments
Table 125. BrioHealth Solutions Corporation Information
Table 126. BrioHealth Solutions Description and Major Businesses
Table 127. BrioHealth Solutions Product Models, Descriptions and Specifications
Table 128. BrioHealth Solutions Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 129. BrioHealth Solutions Recent Developments
Table 130. Hanyu Medical Corporation Information
Table 131. Hanyu Medical Description and Major Businesses
Table 132. Hanyu Medical Product Models, Descriptions and Specifications
Table 133. Hanyu Medical Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 134. Hanyu Medical Recent Developments
Table 135. NewMed Medical Corporation Information
Table 136. NewMed Medical Description and Major Businesses
Table 137. NewMed Medical Product Models, Descriptions and Specifications
Table 138. NewMed Medical Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 139. NewMed Medical Recent Developments
Table 140. Valgen Medtech Corporation Information
Table 141. Valgen Medtech Description and Major Businesses
Table 142. Valgen Medtech Product Models, Descriptions and Specifications
Table 143. Valgen Medtech Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 144. Valgen Medtech Recent Developments
Table 145. Key Raw Materials Distribution
Table 146. Raw Materials Key Suppliers
Table 147. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 148. Milestones in Production Technology Evolution
Table 149. Distributors List
Table 150. Market Trends and Market Evolution
Table 151. Market Drivers and Opportunities
Table 152. Market Challenges, Risks, and Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Heart Failure Treatment Devices Product Picture
Figure 2. Global Heart Failure Treatment Devices Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Mechanical Assistance Type Product Picture
Figure 4. Electrical Related Technology Product Picture
Figure 5. Structural Improvement Type Product Picture
Figure 6. Global Heart Failure Treatment Devices Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. GradeⅠ- Ⅳ
Figure 8. Grade Ⅱ- Ⅳ
Figure 9. Grade Ⅲ -IV
Figure 10. Heart Failure Treatment Devices Report Years Considered
Figure 11. Global Heart Failure Treatment Devices Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Heart Failure Treatment Devices Revenue (2020-2031) & (US$ Million)
Figure 13. Global Heart Failure Treatment Devices Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Heart Failure Treatment Devices Revenue Market Share by Region (2020-2031)
Figure 15. Global Heart Failure Treatment Devices Sales (2020-2031) & (Units)
Figure 16. Global Heart Failure Treatment Devices Sales (CAGR) by Region (2020-2031) (Units)
Figure 17. Global Heart Failure Treatment Devices Sales Market Share by Region (2020-2031)
Figure 18. Top 5 and Top 10 Manufacturers Heart Failure Treatment Devices Sales Volume Market Share in 2024
Figure 19. Global Heart Failure Treatment Devices Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. Mechanical Assistance Type Revenue Market Share by Manufacturer in 2024
Figure 22. Electrical Related Technology Revenue Market Share by Manufacturer in 2024
Figure 23. Structural Improvement Type Revenue Market Share by Manufacturer in 2024
Figure 24. Global Heart Failure Treatment Devices Sales Market Share by Type (2020-2031)
Figure 25. Global Heart Failure Treatment Devices Revenue Market Share by Type (2020-2031)
Figure 26. Global Heart Failure Treatment Devices Sales Market Share by Application (2020-2031)
Figure 27. Global Heart Failure Treatment Devices Revenue Market Share by Application (2020-2031)
Figure 28. North America Heart Failure Treatment Devices Sales YoY (2020-2031) & (Units)
Figure 29. North America Heart Failure Treatment Devices Revenue YoY (2020-2031) & (US$ Million)
Figure 30. North America Top 5 Manufacturers Heart Failure Treatment Devices Sales Revenue (US$ Million) in 2024
Figure 31. North America Heart Failure Treatment Devices Sales Volume (Units) by Type (2020- 2031)
Figure 32. North America Heart Failure Treatment Devices Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 33. North America Heart Failure Treatment Devices Sales Volume (Units) by Application (2020-2031)
Figure 34. North America Heart Failure Treatment Devices Sales Revenue (US$ Million) by Application (2020-2031)
Figure 35. US Heart Failure Treatment Devices Revenue (2020-2031) & (US$ Million)
Figure 36. Canada Heart Failure Treatment Devices Revenue (2020-2031) & (US$ Million)
Figure 37. Mexico Heart Failure Treatment Devices Revenue (2020-2031) & (US$ Million)
Figure 38. Europe Heart Failure Treatment Devices Sales YoY (2020-2031) & (Units)
Figure 39. Europe Heart Failure Treatment Devices Revenue YoY (2020-2031) & (US$ Million)
Figure 40. Europe Top 5 Manufacturers Heart Failure Treatment Devices Sales Revenue (US$ Million) in 2024
Figure 41. Europe Heart Failure Treatment Devices Sales Volume (Units) by Type (2020-2031)
Figure 42. Europe Heart Failure Treatment Devices Sales Revenue (US$ Million) by Type (2020-2031)
Figure 43. Europe Heart Failure Treatment Devices Sales Volume (Units) by Application (2020-2031)
Figure 44. Europe Heart Failure Treatment Devices Sales Revenue (US$ Million) by Application (2020-2031)
Figure 45. Germany Heart Failure Treatment Devices Revenue (2020-2031) & (US$ Million)
Figure 46. France Heart Failure Treatment Devices Revenue (2020-2031) & (US$ Million)
Figure 47. U.K. Heart Failure Treatment Devices Revenue (2020-2031) & (US$ Million)
Figure 48. Italy Heart Failure Treatment Devices Revenue (2020-2031) & (US$ Million)
Figure 49. Russia Heart Failure Treatment Devices Revenue (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Heart Failure Treatment Devices Sales YoY (2020-2031) & (Units)
Figure 51. Asia-Pacific Heart Failure Treatment Devices Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific Top 8 Manufacturers Heart Failure Treatment Devices Sales Revenue (US$ Million) in 2024
Figure 53. Asia-Pacific Heart Failure Treatment Devices Sales Volume (Units) by Type (2020- 2031)
Figure 54. Asia-Pacific Heart Failure Treatment Devices Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 55. Asia-Pacific Heart Failure Treatment Devices Sales Volume (Units) by Application (2020-2031)
Figure 56. Asia-Pacific Heart Failure Treatment Devices Sales Revenue (US$ Million) by Application (2020-2031)
Figure 57. Indonesia Heart Failure Treatment Devices Revenue (2020-2031) & (US$ Million)
Figure 58. Japan Heart Failure Treatment Devices Revenue (2020-2031) & (US$ Million)
Figure 59. South Korea Heart Failure Treatment Devices Revenue (2020-2031) & (US$ Million)
Figure 60. China Taiwan Heart Failure Treatment Devices Revenue (2020-2031) & (US$ Million)
Figure 61. India Heart Failure Treatment Devices Revenue (2020-2031) & (US$ Million)
Figure 62. Central and South America Heart Failure Treatment Devices Sales YoY (2020-2031) & (Units)
Figure 63. Central and South America Heart Failure Treatment Devices Revenue YoY (2020-2031) & (US$ Million)
Figure 64. Central and South America Top 5 Manufacturers Heart Failure Treatment Devices Sales Revenue (US$ Million) in 2024
Figure 65. Central and South America Heart Failure Treatment Devices Sales Volume (Units) by Type (2021-2031)
Figure 66. Central and South America Heart Failure Treatment Devices Sales Revenue (US$ Million) by Type (2020-2031)
Figure 67. Central and South America Heart Failure Treatment Devices Sales Volume (Units) by Application (2020-2031)
Figure 68. Central and South America Heart Failure Treatment Devices Sales Revenue (US$ Million) by Application (2020-2031)
Figure 69. Brazil Heart Failure Treatment Devices Revenue (2020-2025) & (US$ Million)
Figure 70. Argentina Heart Failure Treatment Devices Revenue (2020-2025) & (US$ Million)
Figure 71. Middle East, and Africa Heart Failure Treatment Devices Sales YoY (2020-2031) & (Units)
Figure 72. Middle East and Africa Heart Failure Treatment Devices Revenue YoY (2020-2031) & (US$ Million)
Figure 73. Middle East and Africa Top 5 Manufacturers Heart Failure Treatment Devices Sales Revenue (US$ Million) in 2024
Figure 74. Middle East and Africa Heart Failure Treatment Devices Sales Volume (Units) by Type (2021-2031)
Figure 75. South America Heart Failure Treatment Devices Sales Revenue (US$ Million) by Type (2020-2031)
Figure 76. Middle East and Africa Heart Failure Treatment Devices Sales Volume (Units) by Application (2020-2031)
Figure 77. Middle East and Africa Heart Failure Treatment Devices Sales Revenue (US$ Million) by Application (2020-2031)
Figure 78. GCC Countries Heart Failure Treatment Devices Revenue (2020-2025) & (US$ Million)
Figure 79. Turkey Heart Failure Treatment Devices Revenue (2020-2025) & (US$ Million)
Figure 80. Egypt Heart Failure Treatment Devices Revenue (2020-2025) & (US$ Million)
Figure 81. South Africa Heart Failure Treatment Devices Revenue (2020-2025) & (US$ Million)
Figure 82. Heart Failure Treatment Devices Industry Chain Mapping
Figure 83. Regional Heart Failure Treatment Devices Manufacturing Base Distribution (%)
Figure 84. Global Heart Failure Treatment Devices Production Market Share by Region (2020-2031)
Figure 85. Heart Failure Treatment Devices Production Process
Figure 86. Regional Heart Failure Treatment Devices Production Cost Structure
Figure 87. Channels of Distribution (Direct Vs Distribution)
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232